Both Inpefa and Invokana offer similar effectiveness in symptom control, with the main difference being how quickly they act. Either drug is a viable option depending on the patient’s needs.

Both Inpefa and Invokana have similar safety profiles, with mild and transient side effects. Neither presents significant long-term safety concerns.

Both Inpefa and Invokana have a low risk of addiction when used correctly under medical supervision, with minimal potential for misuse.

Both Inpefa and Invokana are easy to use, with straightforward dosing regimens that ensure good adherence.

Invokana is better for patients with cardiovascular or diabetes-related issues, as it has fewer interactions with other medications.

Both drugs offer advantages depending on treatment goals. Inpefa is great for fast relief, while Invokana is better for long-term management. The choice depends on the patient’s specific needs.